Core Scientific’s (CORZ) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Core Scientific (NASDAQ:CORZ) in a research note released on Wednesday,Benzinga reports. They currently have a $39.00 price objective on the stock.

CORZ has been the topic of a number of other research reports. BTIG Research restated a “buy” rating and issued a $38.00 target price on shares of Core Scientific in a report on Tuesday, July 28th. Wells Fargo & Company started coverage on shares of Core Scientific in a research report on Thursday, September 17th. They issued an “overweight” rating and a $28.00 price target on the stock. B. Riley Financial lifted their price target on Core Scientific from $33.00 to $42.00 and gave the company a “buy” rating in a research note on Monday, August 3rd. Freedom Capital upgraded Core Scientific from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. Finally, Rothschild & Co Redburn assumed coverage on Core Scientific in a report on Monday, September 21st. They set a “neutral” rating and a $16.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Core Scientific currently has an average rating of “Moderate Buy” and an average target price of $31.36.

Core Scientific Stock Performance

CORZ opened at $13.48 on Wednesday. The company’s fifty day moving average price is $17.30 and its two-hundred day moving average price is $20.99. Core Scientific has a 1-year low of $12.31 and a 1-year high of $30.46.

Core Scientific (NASDAQ:CORZ) last released its quarterly earnings data on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The business had revenue of $164.20 million for the quarter, compared to analysts’ expectations of $144.83 million. Equities analysts forecast that Core Scientific will post -1.36 earnings per share for the current year.

Insider Activity at Core Scientific

In related news, Director Elizabeth Crain acquired 6,000 shares of the company’s stock in a transaction on Thursday, August 20th. The shares were acquired at an average cost of $18.33 per share, for a total transaction of $109,980.00. Following the purchase, the director owned 71,348 shares in the company, valued at approximately $1,307,808.84. The trade was a 9.18% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Todd DuChene sold 10,000 shares of the firm’s stock in a transaction on Monday, October 12th. The shares were sold at an average price of $15.12, for a total value of $151,200.00. Following the transaction, the insider owned 1,159,668 shares in the company, valued at approximately $17,534,180.16. This trade represents a 0.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders purchased 19,000 shares of company stock valued at $342,290 and sold 100,000 shares valued at $1,881,300. 1.70% of the stock is currently owned by insiders.

Institutional Trading of Core Scientific

Several institutional investors and hedge funds have recently made changes to their positions in CORZ. BlackRock Inc. bought a new position in shares of Core Scientific during the second quarter valued at about $719,649,000. Jericho Capital Asset Management L.P. grew its position in Core Scientific by 11.4% in the 4th quarter. Jericho Capital Asset Management L.P. now owns 13,038,619 shares of the company’s stock worth $189,842,000 after purchasing an additional 1,338,796 shares in the last quarter. Bank of America Corp DE increased its stake in Core Scientific by 412.5% in the 1st quarter. Bank of America Corp DE now owns 4,806,363 shares of the company’s stock valued at $71,903,000 after buying an additional 3,868,535 shares during the last quarter. Clearline Capital LP increased its stake in Core Scientific by 274.2% in the 4th quarter. Clearline Capital LP now owns 4,689,443 shares of the company’s stock valued at $68,278,000 after buying an additional 3,436,127 shares during the last quarter. Finally, Apollo Management Holdings L.P. purchased a new stake in Core Scientific in the 2nd quarter valued at about $115,671,000.

Core Scientific News Roundup

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analyst support remains strong. Cantor Fitzgerald reaffirmed its “Overweight” rating, while Canaccord Genuity and BTIG Research reiterated “Buy” ratings with price targets of $36 and $38, respectively. The broader analyst consensus remains “Moderate Buy,” with an average target of $31.36. Cantor Fitzgerald Reaffirms Overweight Rating for Core Scientific
• Positive Sentiment: Core Scientific’s scheduled third-quarter earnings release on November 5 gives investors a near-term catalyst. Results and management commentary should provide updates on its high-density colocation and artificial-intelligence data-center expansion. Core Scientific Schedules Third Quarter Earnings Release
• Neutral Sentiment: A recent rebound occurred on above-average volume, but Zacks cautioned that current earnings-estimate revisions may not support additional near-term gains. This suggests momentum traders may remain cautious despite the strong analyst targets. Strength Seen in Core Scientific
• Negative Sentiment: Investor risk appetite has weakened for leveraged AI-data-center developers, pressuring Core Scientific alongside Applied Digital and TeraWulf. Concerns about financing costs, valuation, and tenant credit quality—including pressure facing customer CoreWeave—could weigh on the shares. Rotation Out of Debt-Funded AI Builders
• Negative Sentiment: Insider Todd Duchene sold 10,000 shares for approximately $151,200, reducing his position by 0.85%. While the remaining stake is substantial, the transaction adds a modest negative signal. Core Scientific Insider Selling

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.